Balamapimod(863029-99-6)
- Name: Balamapimod
- Synonyms:4-[[3-Chloro-4-[(1-methyl-1H-imidazol-2-yl)thio]phenyl]amino]-6-methoxy-7-[4-(pyrrolidin-1-yl)piperidin-1-yl]quinoline-3-carbonitrile;Balamapimod;MKI 833;
- Molecular Formula:C30H32ClN7OS
- Molecular Weight:574.14
- CAS Registry Number:863029-99-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.863029-99-6 Balamapimod
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.863029-99-6 Balamapimod
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Balamapimod
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
CAS No.863029-99-6 Balamapimod
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
CAS No.863029-99-6 Balamapimod
Assay:97% Appearance:clear liquid Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]

Other Product
- 1134701-31-7/1-O-TOLYL-CYCLOPROPYLAMINE HYDROCHLORIDE
- 26424-46-4/Phenol, 4,4'-(5,7-dimethyltricyclo[3.3.1.13,7]decane-1,3-diyl)bis-
- 78188-48-4/6,6'-Methylenebis-1,3-benzodioxol-5-ol
- 151625-26-2/1,2-Disilanediamine, N1,N1,N2,N2-tetrakis(1-methylethyl)-
- 959617-74-4/3-fluoro-1,5-naphthyridine
- 1086268-91-8/(2E)-4-(Dimethylamino)-2-butenoic acid ethyl ester
- 874101-00-5/3,4-difluoro-2-(2-fluoro-4-iodophenylaMino)-N-(2-hydroxyethoxy)-5-((3-oxoMorpholino)Methyl)benzaMide
- 1032757-09-7/(R)-1-[4-[[2-(2-AMinopyriMidin-5-yl)-7-Methyl-4-(Morpholin-4-yl)thieno[3,2-d]pyriMidin-6-yl]Methyl]piperazin-1-yl]-2-hydroxypropan-1-one
- 122640-83-9/Dicyclohexyl-3,4,3',4'-tetracarboxylic dianhydride
- 58730-35-1/2-(3-aminophenyl)-N-methylacetamide(SALTDATA: FREE)
- 1229617-79-1/2H-1-Benzopyran-2-one, 4-(4-fluorophenyl)-7-(isothiocyanatomethyl)-
- 1129435-60-4/IMMunoglobulin G2
- 935656-56-7/9,10-Bis-(6-tert-butyl-naphthalen-2-yl)-anthracene
- 119175-48-3/Ferrate (Fe(OH)63-), (OC-6-11)-, magnesium carbonate, hydrate (2:4:1:4)
- 2069-20-7/Benzenesulfonamide, 3,4-dichloro-N-[2-chloro-5-(trifluoromethyl)phenyl]-
- 474432-59-2/Pyrazolo[1,5-a]pyridine-5-carboxaldehyde (9CI)
- 426463-16-3/2-FLUORO-5-IODO-3-NITROPYRIDINE
- 97025-16-6/3-(3,5-DIMETHOXY-PHENYL)-3-OXO-PROPIONIC ACID ETHYL ESTER
- 863029-99-6/Balamapimod
- 378746-64-6/Nemonoxacin
- 376592-42-6/3H-Pyrazol-3-one, 2-(3,4-dimethylphenyl)-2,4-dihydro-4-[2-[2-hydroxy-3'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-3-yl]diazenyl]-5-methyl-
- 245765-41-7/Ozenoxacin
- 201034-75-5/2-Propenamide, N-[4-(1-benzoyl-4-piperidinyl)butyl]-3-(3-pyridinyl)-
- 156294-36-9/Larotaxel
- 253128-41-5/Eribulin
- 887148-69-8/Benzamide, N-[(1S)-1-cyano-2-[5-cyano-2-(trifluoromethyl)phenoxy]-1-methylethyl]-4-[(trifluoromethyl)thio]-
- 202844-10-8/Indantadol
- 121524-08-1/Acetic acid, [[(7S)-7-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-5,6,7,8-tetrahydro-2-naphthalenyl]oxy]-, ethyl ester
- 643094-49-9/Fasobegron
- 753449-67-1/Ronacaleret